Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term extension study of ibuprofen gargle in oral lichen planus
jRCTs051220010Phase 2Completed
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ibuprofen in oral lichen planus (OLP). Primary endpoint: Occurrence of adverse event. Started Jun 2022; status: completed.
02
Drugs
ibuprofen
03
Conditions
oral lichen planus (OLP)
Beyond the preview
Go deeper on jRCTs051220010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051220010.